Health Condition 1: C00-D49- Neoplasms Health Condition 2: null- Solid cancer
Conditions
Interventions
None listed
Sponsors
Mitra RxDx India Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1 CANscript test report for solid cancers such as head and neck colorectal gastrointestinal breast ovary lung etc 2 CANscript results with M-score available for at least 1 tested arm 3 Availability of clinical outcome data in terms of tumor responses for respective CANscript tested
Exclusion criteria
Exclusion criteria: (1) No specific exclusion criteria can be defined for the retrospective analysis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Positive and negative prediction rate in overall and each cancer type population 2. Percentage of correctly identified clinical responder and nonresponders, in overall and each cancer type populationTimepoint: [6 weeks] | — |
Secondary
| Measure | Time frame |
|---|---|
| Compare positive, negative predictive values, sensitivity and specificity, in overall and each cancer type population using cohort as cytotoxic and cytostatic class of anti-cancer drugsTimepoint: [6 weeks];Sensitivity and specificity rate in overall and each cancer type populationTimepoint: [6 weeks];Summarize demographics (male, female, age, etc), cancer type and stages, drugs tested â?? alone, combinations, classes as chemotherapy, targeted (small molecules, biologicals, etc) and cytotoxic / cytostatic drugsTimepoint: [6 weeks] | — |
Countries
India
Contacts
Public ContactDr Rahul Rathod
Mitra RxDx India Pvt. Ltd
Outcome results
None listed